INCB3344 is a potent, selective, and orally bioavailable CCR2 antagonist, demonstrating low nanomolar IC50 values in both binding and chemotaxis assays for mouse and human CCR2. It is a valuable research tool for investigating CCR2-mediated pathways in inflammatory and metabolic diseases in both in vitro and in vivo models.